EAM Investors’s SkinHealth Systems SKIN Stock Holding History

EAM Investors’s Portfolio SKIN Stock Details SKIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-106,867	Closed	-$2.58M	–	377
2021 Q4	$2.58M	Sell	106,867 -66,003	-38%	-$1.7M	0.42%	70
2021 Q3	$4.49M	Sell	172,870 -52,920	-23%	-$1.16M	0.76%	10
2021 Q2	$3.79M	Buy	+225,790	New	+$3.09M	0.59%	28

Other funds holding SKIN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

EAM Investors's SKIN Position: Q1 2022 in Review

EAM Investors sold out of SkinHealth Systems (SKIN) in Q1 2022, closing a stake of 106,867 shares — an estimated $2.58M sold.

EAM Investors first reported a position in SKIN in Q2 2021 and held it in 3 quarters. The position peaked at $4.49M in Q3 2021. 164 funds tracked by Wall St. Rank hold SKIN as of Q1 2022.

EAM Investors reported no remaining SkinHealth Systems position as of Q1 2022 after selling out during the quarter.
EAM Investors sold 106,867 SkinHealth Systems shares in Q1 2022, an estimated $2.58M.
EAM Investors first reported a position in SkinHealth Systems in Q2 2021 and held it in 3 quarters.
EAM Investors's SkinHealth Systems position peaked at $4.49M in Q3 2021.
164 funds tracked by Wall St. Rank held SkinHealth Systems as of Q1 2022.

Based on EAM Investors's 13F filing for Q1 2022, filed 13 May 2022.